InvestorsHub Logo
Followers 10
Posts 1111
Boards Moderated 0
Alias Born 04/07/2013

Re: None

Saturday, 11/15/2014 2:39:53 PM

Saturday, November 15, 2014 2:39:53 PM

Post# of 429435
Improve it data will be out Monday and I doubt it will
show benefit. I also feel that it probably won't show
any harm either. The event is irrelevant as Zetia will
stay on the market, but will be replaced by PCSK9 drugs,
as they are so much more effective in lowering LDL. The
REALLY big story in the background is AMGN suing REGN and
SNY over patent infringement of their PCSK9 drug. Amgen
became so enormously successful over the last 30 years
because of their success with patent litigation. They are
tossing a shutout on Patent infringement cases, and probably
will prevail here as well. They are really a Law Firm with
Fermenters. Either way outcomes trials are the future of
Cardiology drugs. It will have zero impact on AMRN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News